Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Behavioral and Pharmacological Manipulation of Time Cell Activity in the Human Mesial Temporal Lobe
NCT05594017Phase 1Recruiting
- Sponsor
- UT Southwestern Medical Center
- Start
- Aug 2019
- Primary completion
- Nov 2027
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial comparing Scopolamine (0.4mg) with Placebo (2 arms). Primary endpoint: Memory-related changes in brain electrical activity in participants from baseline at Day 2. Started Aug 2019; status: recruiting.
02
Drugs
scopolamine
Beyond the preview
Go deeper on NCT05594017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05594017.